[Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions].
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000627:therapeutic use; D003864:Depression, Chemical; D003975:Diazepam / Q000008:administration & dosage / Q000627:therapeutic use; D004357:Drug Synergism; D004597:Electroshock; D004644:Emotions / Q000187:drug effects; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D001523:Mental Disorders / Q000188:drug therapy*; D008620:Meprobamate / Q000008:administration & dosage; D051379:Mice; D009025:Morpholines / Q000008:administration & dosage; D009068:Movement / Q000187:drug effects*; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009497:Neurotic Disorders / Q000188:drug therapy; D009949:Orientation / Q000187:drug effects; D010076:Oxazepam / Q000008:administration & dosage / Q000627:therapeutic use; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D013331:Strychnine / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000627:therapeutic use* / Q000633:toxicity
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D009025:Morpholines; D009125:Muscle Relaxants, Central; D014149:Tranquilizing Agents; D010076:Oxazepam; D002707:Chlordiazepoxide; D008620:Meprobamate; D006591:Hexobarbital; D013331:Strychnine; D003975:Diazepam; D010433:Pentylenetetrazole
Sopostavlenie osobennosteĭ deĭstviia trankvilizatorov v eksperimente i v klinike.